These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 3516408)

  • 1. Dihydroergotamine nasal spray in the treatment of attacks of cluster headache. A double-blind trial versus placebo.
    Andersson PG; Jespersen LT
    Cephalalgia; 1986 Mar; 6(1):51-4. PubMed ID: 3516408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydroergotamine nasal spray during migraine attacks. A double-blind crossover study with placebo.
    Tulunay FC; Karan O; Aydin N; Culcuoglu A; Guvener A
    Cephalalgia; 1987 Jun; 7(2):131-3. PubMed ID: 3301001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydroergotamine nasal spray for the acute treatment of migraine.
    Ziegler D; Ford R; Kriegler J; Gallagher RM; Peroutka S; Hammerstad J; Saper J; Hoffert M; Vogel B; Holtz N
    Neurology; 1994 Mar; 44(3 Pt 1):447-53. PubMed ID: 8145914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repetitive dihydroergotamine nasal spray for treatment of refractory headaches: an open-label pilot study.
    Weintraub J
    Curr Med Res Opin; 2006 Oct; 22(10):2031-6. PubMed ID: 17022862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy, safety, and tolerability of dihydroergotamine nasal spray as monotherapy in the treatment of acute migraine. Dihydroergotamine Nasal Spray Multicenter Investigators.
    Headache; 1995 Apr; 35(4):177-84. PubMed ID: 7775172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical comparison of sumatriptan nasal spray and dihydroergotamine nasal spray in the acute treatment of migraine.
    Boureau F; Kappos L; Schoenen J; Esperanca P; Ashford E
    Int J Clin Pract; 2000 Jun; 54(5):281-6. PubMed ID: 10954953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydroergotamine nasal spray in the treatment of acute migraine.
    Treves TA; Kuritzky A; Hering R; Korczyn AD
    Headache; 1998 Sep; 38(8):614-7. PubMed ID: 11398305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of subcutaneous sumatriptan and dihydroergotamine nasal spray in the acute treatment of migraine.
    Touchon J; Bertin L; Pilgrim AJ; Ashford E; Bès A
    Neurology; 1996 Aug; 47(2):361-5. PubMed ID: 8757005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of intranasal zolmitriptan in acute cluster headache: a randomized, placebo-controlled, double-blind crossover study.
    Cittadini E; May A; Straube A; Evers S; Bussone G; Goadsby PJ
    Arch Neurol; 2006 Nov; 63(11):1537-42. PubMed ID: 16966497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydroergotamine nasal spray for relief of refractory headache: a retrospective chart review.
    Fisher M; Gosy EJ; Heary B; Shaw D
    Curr Med Res Opin; 2007 Apr; 23(4):751-5. PubMed ID: 17407631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zolmitriptan nasal spray in the acute treatment of cluster headache: a double-blind study.
    Rapoport AM; Mathew NT; Silberstein SD; Dodick D; Tepper SJ; Sheftell FD; Bigal ME
    Neurology; 2007 Aug; 69(9):821-6. PubMed ID: 17724283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug management of adult vascular headaches (migraine and cluster headache): Part I--Treatment of the acute attack.
    Damasio H
    Iowa Med; 1984 Nov; 74(11):490-2. PubMed ID: 6511281
    [No Abstract]   [Full Text] [Related]  

  • 13. Venoconstrictor effects of dihydroergotamine after intranasal and intramuscular administration.
    Aellig WH; Rosenthaler J
    Eur J Clin Pharmacol; 1986; 30(5):581-4. PubMed ID: 3758146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of single-dose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache.
    Belgrade MJ; Ling LJ; Schleevogt MB; Ettinger MG; Ruiz E
    Neurology; 1989 Apr; 39(4):590-2. PubMed ID: 2648190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suboccipital steroid injections for transitional treatment of patients with more than two cluster headache attacks per day: a randomised, double-blind, placebo-controlled trial.
    Leroux E; Valade D; Taifas I; Vicaut E; Chagnon M; Roos C; Ducros A
    Lancet Neurol; 2011 Oct; 10(10):891-7. PubMed ID: 21903477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydroergotamine mesylate nasal spray: an acute treatment option for migraine in adults.
    Silvestro M; Orologio I; Tessitore A; Trojsi F; Tedeschi G; Russo A
    Expert Rev Neurother; 2024 Jun; 24(6):555-564. PubMed ID: 38655598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Betablocker vs placebo in vasomotor headache. A double-blind crossover study].
    Grotemeyer KH; Husstedt IW; Schlake HP
    Dtsch Med Wochenschr; 1987 Nov; 112(45):1740-3. PubMed ID: 2890509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of migraine attacks: combination of dihydroergotamine tartrate and paracetamol in comparison with individual drugs and placebo].
    Hoernecke R; Doenicke A
    Med Klin (Munich); 1993 Nov; 88(11):642-8. PubMed ID: 8295604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pain relief by somatostatin in attacks of cluster headache.
    Sicuteri F; Geppetti P; Marabini S; Lembeck F
    Pain; 1984 Apr; 18(4):359-365. PubMed ID: 6145138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zolmitriptan nasal spray in the acute treatment of cluster headache: a meta-analysis of two studies.
    Hedlund C; Rapoport AM; Dodick DW; Goadsby PJ
    Headache; 2009 Oct; 49(9):1315-23. PubMed ID: 19788472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.